Home > Qtrly Results > Sun Pharmaceutical Industries

Sun Pharmaceutical Industries
Quarterly Results Analysis [Mar2022]

Sun Pharmaceutical Industries is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Top Undervalued Large Cap Stocks
COMMUNITY POLL
for Sun Pharmaceutical Industries
Please provide your vote to see the results

Sun Pharmaceutical Industries Quarterly Results

Consolidated Mar2022
Audited
Dec2021
UnAudited
Sep2021
UnAudited
Jun2021
Audited
Mar2021
Audited
Dec2020
UnAudited
Sep2020
UnAudited
Jun2020
Audited
Revenues ₹9,447 Cr ₹9,863 Cr ₹9,626 Cr ₹9,719 Cr ₹8,523 Cr ₹8,837 Cr ₹8,553 Cr ₹7,585 Cr
Expenses ₹7,267 Cr ₹7,257 Cr ₹6,996 Cr ₹6,978 Cr ₹6,475 Cr ₹6,502 Cr ₹6,360 Cr ₹5,821 Cr
Operating Income ₹2,179 Cr ₹2,606 Cr ₹2,630 Cr ₹2,741 Cr ₹2,048 Cr ₹2,335 Cr ₹2,193 Cr ₹1,764 Cr
Other Income ₹275 Cr ₹433 Cr ₹223 Cr ₹232 Cr ₹111 Cr ₹387 Cr ₹256 Cr ₹233 Cr
Interest ₹37 Cr ₹19 Cr ₹36 Cr ₹35 Cr ₹30 Cr ₹26 Cr ₹33 Cr ₹52 Cr
Depreciation ₹556 Cr ₹554 Cr ₹530 Cr ₹503 Cr ₹553 Cr ₹532 Cr ₹499 Cr ₹496 Cr
Profit Before Tax ₹-2,076 Cr ₹2,466 Cr ₹2,287 Cr ₹1,804 Cr ₹903 Cr ₹2,163 Cr ₹1,917 Cr ₹-2,184 Cr
Profit After Tax ₹-2,222 Cr ₹2,131 Cr ₹2,089 Cr ₹1,409 Cr ₹848 Cr ₹1,918 Cr ₹1,948 Cr ₹-2,430 Cr
EPS ₹-9.49 ₹8.58 ₹8.53 ₹6.02 ₹3.73 ₹7.72 ₹7.56 ₹-6.90
Industry Peers & Returns1W1M1Y
Sun Pharmaceutical Industries -1.1% -3.8% 22.7%
DIVIS LABORATORIES -1.1% 3.1% -14.6%
DR REDDYS LABORATORIES 1.6% 1.2% -17.2%
CIPLA 1.9% -3.8% -6.5%
GLAND PHARMA -0.1% -6.5% -20.6%
PIRAMAL ENTERPRISES 0.3% -8% -31.3%
CADILA HEALTHCARE 2.3% -0.8% -44.3%
TORRENT PHARMACEUTICALS 1.9% 3.6% -2.1%
ALKEM LABORATORIES -0.4% -2.4% -6.2%

Sun Pharmaceutical Industries Quarterly Revenues

Revenues
Q-o-Q

-4.22 %

Y-o-Y

10.84 %

Quarters Revenues % Change
Mar2022 ₹9,447 Cr
-4.22
Dec2021 ₹9,863 Cr
2.46
Sep2021 ₹9,626 Cr
-0.95
Jun2021 ₹9,719 Cr
14.03
Mar2021 ₹8,523 Cr
-3.55
Dec2020 ₹8,837 Cr
3.32
Sep2020 ₹8,553 Cr
12.76
Jun2020 ₹7,585 Cr -

Sun Pharmaceutical Industries Quarterly Operating Profit

Operating Profit
Q-o-Q

-16.38 %

Y-o-Y

6.39 %

Quarters Operating Profit % Change
Mar2022 ₹2,179 Cr
-16.38
Dec2021 ₹2,606 Cr
-0.90
Sep2021 ₹2,630 Cr
-4.06
Jun2021 ₹2,741 Cr
33.82
Mar2021 ₹2,048 Cr
-12.25
Dec2020 ₹2,335 Cr
6.44
Sep2020 ₹2,193 Cr
24.31
Jun2020 ₹1,764 Cr -
Operating Margins
Q-o-Q

-12.71 %

Y-o-Y

-4.00 %

Quarters Operating Margin% % Change
Mar2022 23.07%
-12.71
Dec2021 26.43%
-3.26
Sep2021 27.32%
-3.15
Jun2021 28.21%
17.39
Mar2021 24.03%
-9.05
Dec2020 26.42%
3.04
Sep2020 25.64%
10.23
Jun2020 23.26% -

Sun Pharmaceutical Industries Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

Negative

Y-o-Y

Negative

Quarters Profit After Tax % Change
Mar2022 ₹-2,222 Cr
Negative
Dec2021 ₹2,131 Cr
2.01
Sep2021 ₹2,089 Cr
48.28
Jun2021 ₹1,409 Cr
66.11
Mar2021 ₹848 Cr
-55.79
Dec2020 ₹1,918 Cr
-1.55
Sep2020 ₹1,948 Cr
Positive
Jun2020 ₹-2,430 Cr -
PAT Margins
Q-o-Q

Negative

Y-o-Y

Negative

Quarters PAT Margin(%) % Change
Mar2022 -23.53 %
Negative
Dec2021 21.6 %
-0.46
Sep2021 21.7 %
49.76
Jun2021 14.49 %
45.63
Mar2021 9.95 %
-54.17
Dec2020 21.71 %
-4.70
Sep2020 22.78 %
Positive
Jun2020 -32.03 % -

Sun Pharmaceutical Industries Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

Negative

Y-o-Y

Negative

Quarters EPS % Change
Mar2022 ₹-9.49
Negative
Dec2021 ₹8.58
0.59
Sep2021 ₹8.53
41.69
Jun2021 ₹6.02
61.39
Mar2021 ₹3.73
-51.68
Dec2020 ₹7.72
2.12
Sep2020 ₹7.56
Positive
Jun2020 ₹-6.9 -

You may also like the below Video Courses


SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].